Mechanistic Insights of Chemicals and Drugs as Risk Factors for Systemic Lupus Erythematosus

(E-pub Ahead of Print)

Author(s): Qingjun Pan*, Yun Guo*, Linjie Guo*, Shuzhen Liao, Chunfei Zhao, Sijie Wang, Hua-feng Liu.

Journal Name: Current Medicinal Chemistry

Become EABM
Become Reviewer

Abstract:

Systemic lupus erythematosus (SLE) is a chronic and relapsing heterogenous autoimmune disease that primarily affects women of reproductive age. Genetic and environmental risk factors are involved in the pathogenesis of SLE, and susceptibility genes have recently been identified. However, as gene therapy is far from clinical application, further investigation of environmental risk factors could reveal important therapeutic approaches. We systematically explored two groups of environmental risk factors: chemicals (including silica, solvents, pesticides, hydrocarbons, heavy metals, and particulate matter) and drugs (including procainamide, hydralazine, quinidine, D-penicillamine, isoniazid, and methyldopa). Furthermore, the mechanisms underlying risk factors, such as genetic factors, epigenetic change, and disrupted immune tolerance, were explored. This review identifies novel risk factors, and their underlying mechanisms. Practicable measures for the management of these risk factors will benefit SLE patients and provide potential therapeutic strategies.

Keywords: Risk factors, systemic lupus erythematosus, autoimmunity, genetic factors, epigenetic change, immune tolerance.

Rights & PermissionsPrintExport Cite as


Article Details

(E-pub Ahead of Print)
DOI: 10.2174/0929867326666190404140658
Price: $95